NumerixS Investment Technologies’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-3,108
Closed -$117K 604
2020
Q2
$117K Buy
3,108
+1,100
+55% +$44K 0.03% 541
2020
Q1
$74K Buy
+2,008
New +$78K 0.04% 509
2019
Q4
Sell
-800
Closed -$28K 1190
2019
Q3
$28K Buy
+800
New +$26.4K 0.01% 848
2018
Q4
Sell
-1,000
Closed -$38K 1292
2018
Q3
$38K Buy
1,000
+800
+400% +$30.3K 0.01% 1018
2018
Q2
$8K Buy
+200
New +$6.74K ﹤0.01% 1062
2018
Q1
Sell
-6,800
Closed -$302K 1222
2017
Q4
$302K Buy
6,800
+5,200
+325% +$237K 0.07% 333
2017
Q3
$80K Buy
1,600
+600
+60% +$30.7K 0.02% 821
2017
Q2
$53K Buy
1,000
+100
+11% +$5.36K 0.01% 946
2017
Q1
$50K Buy
+900
New +$49.6K 0.01% 1014
2016
Q2
Sell
-9,040
Closed -$483K 1210
2016
Q1
$483K Buy
+9,040
New +$445K 0.06% 480

Other funds holding PBH

NumerixS Investment Technologies's PBH Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of Prestige Consumer Healthcare (PBH) in Q3 2020, closing a stake of 3,108 shares — an estimated $117K sold.

NumerixS Investment Technologies first reported a position in PBH in Q1 2016 and held it in 10 quarters. The position peaked at $483K in Q1 2016. 242 funds tracked by Wall St. Rank hold PBH as of Q3 2020.

  • NumerixS Investment Technologies reported no remaining Prestige Consumer Healthcare position as of Q3 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 3,108 Prestige Consumer Healthcare shares in Q3 2020, an estimated $117K.
  • NumerixS Investment Technologies first reported a position in Prestige Consumer Healthcare in Q1 2016 and held it in 10 quarters.
  • NumerixS Investment Technologies's Prestige Consumer Healthcare position peaked at $483K in Q1 2016.
  • 242 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.